Cogent Biosciences, Inc. (COGT)
32.62
+1.24
(+3.97%)
USD |
NASDAQ |
Jun 11, 16:00
32.62
0.00 (0.00%)
After-Hours: 19:33
Cogent Biosciences Accounts Payable (Quarterly) : 13.74M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 13.74M |
| December 31, 2025 | 9.504M |
| September 30, 2025 | 16.03M |
| June 30, 2025 | 16.62M |
| March 31, 2025 | 14.15M |
| December 31, 2024 | 12.01M |
| September 30, 2024 | 15.06M |
| June 30, 2024 | 8.975M |
| March 31, 2024 | 15.56M |
| December 31, 2023 | 10.66M |
| September 30, 2023 | 9.868M |
| June 30, 2023 | 7.161M |
| March 31, 2023 | 4.172M |
| December 31, 2022 | 5.842M |
| September 30, 2022 | 4.093M |
| June 30, 2022 | 3.492M |
| March 31, 2022 | 4.015M |
| December 31, 2021 | 3.483M |
| Date | Value |
|---|---|
| September 30, 2021 | 4.349M |
| June 30, 2021 | 1.992M |
| March 31, 2021 | 0.315M |
| December 31, 2020 | 0.732M |
| September 30, 2020 | 0.639M |
| June 30, 2020 | 0.632M |
| March 31, 2020 | 0.628M |
| December 31, 2019 | 3.183M |
| September 30, 2019 | 1.594M |
| June 30, 2019 | 1.66M |
| March 31, 2019 | 1.836M |
| December 31, 2018 | 1.519M |
| September 30, 2018 | 0.803M |
| June 30, 2018 | 1.664M |
| March 31, 2018 | 3.083M |
| December 31, 2017 | 1.346M |
| September 30, 2017 | 2.012M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Vera Therapeutics, Inc. | 13.91M |
| Replimune Group, Inc. | 5.647M |
| Vir Biotechnology, Inc. | 5.445M |
| Revolution Medicines, Inc. | 80.54M |
| Vaxcyte, Inc. | 63.06M |